{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T00:19:48Z","timestamp":1791937188096,"version":"4.3.4"},"update-to":[{"DOI":"10.1002\/14651858.cd009183","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2011,10,5]],"date-time":"2011-10-05T00:00:00Z","timestamp":1317772800000}}],"reference-count":46,"publisher":"Wiley","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd009183.pub2","type":"journal-article","created":{"date-parts":[[2011,9,28]],"date-time":"2011-09-28T16:34:03Z","timestamp":1317227643000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":42,"title":["Valproic acid and sodium valproate for neuropathic pain and fibromyalgia in adults"],"prefix":"10.1002","author":[{"given":"Dipender","family":"Gill","sequence":"additional","affiliation":[{"name":"Pain Research and Nuffield Department of Clinical Neurosciences (Nuffield Division of Anaesthetics); University of Oxford; Oxford UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheena","family":"Derry","sequence":"additional","affiliation":[{"name":"Oxford UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip J","family":"Wiffen","sequence":"additional","affiliation":[{"name":"Thame UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R Andrew","family":"Moore","sequence":"additional","affiliation":[{"name":"Plymouth UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2011,10,5]]},"reference":[{"issue":"3","key":"10.1002\/14651858.CD009183.pub2-BIB0001|cit1","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1016\/j.diabres.2008.12.018","article-title":"Management of diabetic neuropathy by sodium valproate and glyceryl trinitrate spray: a prospective double-blind randomized placebo-controlled study","volume":"83","author":"Agrawal","year":"2009","journal-title":"Diabetes Research and Clinical Practice"},{"issue":"1","key":"10.1002\/14651858.CD009183.pub2-BIB0002|cit2","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1093\/qjmed\/hch007","article-title":"Sodium valproate for painful diabetic neuropathy: a randomized double-blind placebo-controlled study","volume":"97","author":"Kochar","year":"2004","journal-title":"QJM: Journal of the Association of Physicians"},{"issue":"1","key":"10.1002\/14651858.CD009183.pub2-BIB0003|cit3","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1093\/qjmed\/hci005","article-title":"Divalproex sodium in the management of post-herpetic neuralgia: a randomized double-blind placebo-controlled study","volume":"98","author":"Kochar","year":"2005","journal-title":"QJM: Journal of the Association of Physicians"},{"issue":"8","key":"10.1002\/14651858.CD009183.pub2-BIB0004|cit4","first-page":"565","article-title":"Valproate for treatment of chronic central pain after spinal cord injury. A double-blind cross-over study","volume":"32","author":"Drewes","year":"1994","journal-title":"Paraplegia"},{"issue":"3","key":"10.1002\/14651858.CD009183.pub2-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/S0885-3924(00)00266-9","article-title":"A phase II study to establish the efficacy and toxicity of sodium valproate in patients with cancer-related neuropathic pain","volume":"21","author":"Hardy","year":"2001","journal-title":"Journal of Pain and Symptom Management"},{"issue":"5","key":"10.1002\/14651858.CD009183.pub2-BIB0006|cit6","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1034\/j.1600-0404.2002.01229.x","article-title":"Sodium valproate in the management of painful neuropathy in type 2 diabetes - a randomized placebo controlled study","volume":"106","author":"Kochar","year":"2002","journal-title":"Acta Neurologica Scandinavica"},{"issue":"2","key":"10.1002\/14651858.CD009183.pub2-BIB0007|cit7","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1212\/WNL.62.2.285","article-title":"Valproic acid has no effect on pain in polyneuropathy: a randomized, controlled trial","volume":"62","author":"Otto","year":"2004","journal-title":"Neurology"},{"key":"10.1002\/14651858.CD009183.pub2-BIB0008|cit8","unstructured":"Treatment of painful diabetic neuropathy www.aan.com\/globals\/axon\/assets\/8400.pdf [accessed 5 August 2011]"},{"issue":"11","key":"10.1002\/14651858.CD009183.pub2-BIB0009|cit9","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1111\/j.1468-1331.2006.01511.x","article-title":"EFNS guidelines on pharmacological treatment of neuropathic pain","volume":"13","author":"Attal","year":"2006","journal-title":"European Journal of Neurology"},{"issue":"5 (Suppl 2)","key":"10.1002\/14651858.CD009183.pub2-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"S14","DOI":"10.1212\/WNL.59.5_suppl_2.S14","article-title":"Use of anticonvulsants for treatment of neuropathic pain","volume":"59","author":"Backonja","year":"2002","journal-title":"Neurology"},{"issue":"6","key":"10.1002\/14651858.CD009183.pub2-BIB0011|cit11","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/S0885-3924(00)00218-9","article-title":"Antidepressants and anticonvulsants for diabetic neuropathy and postherpetic neuralgia: a quantitative systematic review","volume":"20","author":"Collins","year":"2000","journal-title":"Journal of Pain and Symptom Management"},{"issue":"2","key":"10.1002\/14651858.CD009183.pub2-BIB0012|cit12","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.jpain.2007.09.005","article-title":"Interpreting the clinical importance of treatment outcomes in chronic pain clinical trials: IMMPACT recommendations","volume":"9","author":"Dworkin","year":"2008","journal-title":"Journal of Pain"},{"issue":"3 Suppl","key":"10.1002\/14651858.CD009183.pub2-BIB0013|cit13","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.4065\/mcp.2009.0649","article-title":"Recommendations for the pharmacological management of neuropathic pain: an overview and literature update","volume":"85","author":"Dworkin","year":"2010","journal-title":"Mayo Clinic Proceedings"},{"issue":"3","key":"10.1002\/14651858.CD009183.pub2-BIB0014|cit14","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/j.pain.2005.08.013","article-title":"Algorithm for neuropathic pain treatment: an evidence based proposal","volume":"118","author":"Finnerup","year":"2006","journal-title":"Pain"},{"issue":"2","key":"10.1002\/14651858.CD009183.pub2-BIB0015|cit15","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1517\/14656566.9.2.285","article-title":"Oral valproic acid for epilepsy - long-term experience in therapy and side effects","volume":"9","author":"Gerstner","year":"2008","journal-title":"Expert Opinion in Pharmacotherapy"},{"issue":"1","key":"10.1002\/14651858.CD009183.pub2-BIB0016|cit16","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1111\/j.1399-6576.2007.01486.x","article-title":"Prevalence of self-reported neuropathic pain and impact on quality of life: a prospective representative survey","volume":"52","author":"Gustorff","year":"2008","journal-title":"Acta Anaesthesiologica Scandinavica"},{"issue":"1-2","key":"10.1002\/14651858.CD009183.pub2-BIB0017|cit17","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.pain.2006.01.030","article-title":"Epidemiology and treatment of neuropathic pain: the UK primary care perspective","volume":"122","author":"Hall","year":"2006","journal-title":"Epidemiology and treatment of neuropathic pain: the UK primary care perspective"},{"key":"10.1002\/14651858.CD009183.pub2-BIB0018|cit18","article-title":"A new definition of neuropathic pain","volume":"[E pub July 14]","author":"Jensen","year":"2011","journal-title":"Pain"},{"issue":"11","key":"10.1002\/14651858.CD009183.pub2-BIB0019|cit19","doi-asserted-by":"crossref","first-page":"982","DOI":"10.7326\/0003-4819-135-11-200112040-00010","article-title":"Reported methodologic quality and discrepancies between large and small randomized trials in meta-analyses","volume":"135","author":"Kjaergard","year":"2001","journal-title":"Annals of Internal Medicine"},{"issue":"3","key":"10.1002\/14651858.CD009183.pub2-BIB0020|cit20","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1055\/s-2008-1079337","article-title":"Teratogenicity of antiepileptic medications","volume":"28","author":"Kluger","year":"2008","journal-title":"Seminars in Neurolology"},{"key":"10.1002\/14651858.CD009183.pub2-BIB0021|cit21","doi-asserted-by":"crossref","first-page":"224","DOI":"10.7326\/0003-4819-107-2-224","article-title":"Meta-analysis in clinical research","volume":"107","author":"L'Abb\u00e9","year":"1987","journal-title":"Annals of Internal Medicine"},{"issue":"4","key":"10.1002\/14651858.CD009183.pub2-BIB0022|cit22","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD007115.pub2","article-title":"Duloxetine for treating painful neuropathy or chronic pain","author":"Lunn","year":"2009","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"7012","key":"10.1002\/14651858.CD009183.pub2-BIB0023|cit23","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1136\/bmj.311.7012.1047","article-title":"Anticonvulsant drugs for management of pain: a systematic review","volume":"311","author":"McQuay","year":"1995","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD009183.pub2-BIB0024|cit24","volume-title":"An evidence-based resource for pain relief","author":"McQuay","year":"1998"},{"key":"10.1002\/14651858.CD009183.pub2-BIB0025|cit25","first-page":"519","volume-title":"Health Care Needs Assessment","author":"McQuay","year":"2007"},{"issue":"3","key":"10.1002\/14651858.CD009183.pub2-BIB0026|cit26","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/S0304-3959(98)00140-7","article-title":"Size is everything - large amounts of information are needed to overcome random effects in estimating direction and magnitude of treatment effects","volume":"78","author":"Moore","year":"1998","journal-title":"Pain"},{"issue":"3","key":"10.1002\/14651858.CD009183.pub2-BIB0027|cit27","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1016\/j.pain.2005.05.001","article-title":"Acute pain: individual patient meta-analysis shows the impact of different ways of analysing and presenting results","volume":"116","author":"Moore","year":"2005","journal-title":"Pain"},{"key":"10.1002\/14651858.CD009183.pub2-BIB0028|cit28","first-page":"15","volume-title":"Systematic Reviews in Pain Research: Methodology Refined","author":"Moore","year":"2008"},{"issue":"3","key":"10.1002\/14651858.CD009183.pub2-BIB0029|cit29","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD007076","article-title":"Pregabalin for acute and chronic pain in adults","author":"Moore","year":"2009","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"2","key":"10.1002\/14651858.CD009183.pub2-BIB0030|cit30","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1136\/ard.2009.107805","article-title":"Responder analysis for pain relief and numbers needed to treat in a meta-analysis of etoricoxib osteoarthritis trials: bridging a gap between clinical trials and clinical practice","volume":"69","author":"Moore","year":"2010","journal-title":"Annals of the Rheumatic Diseases"},{"issue":"2","key":"10.1002\/14651858.CD009183.pub2-BIB0031|cit31","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1016\/j.pain.2010.02.039","article-title":"Fibromyalgia: Moderate and substantial pain intensity reduction predicts improvement in other outcomes and substantial quality of life gain","volume":"149","author":"Moore","year":"2010","journal-title":"Pain"},{"issue":"3","key":"10.1002\/14651858.CD009183.pub2-BIB0032|cit32","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/j.pain.2010.05.011","article-title":"\"Evidence\" in chronic pain--establishing best practice in the reporting of systematic reviews","volume":"150","author":"Moore","year":"2010","journal-title":"Pain"},{"issue":"3","key":"10.1002\/14651858.CD009183.pub2-BIB0033|cit33","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD007938.pub2","article-title":"Gabapentin for chronic neuropathic pain and fibromyalgia in adults","author":"Moore","year":"2011","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"1","key":"10.1002\/14651858.CD009183.pub2-BIB0034|cit34","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1155\/2007\/730785","article-title":"Pharmacological management of chronic neuropathic pain - consensus statement and guidelines from the Canadian Pain Society","volume":"12","author":"Moulin","year":"2007","journal-title":"Pain Research and Management"},{"key":"10.1002\/14651858.CD009183.pub2-BIB0035|cit35","unstructured":"National Institute for Health and Clinical Excellence Neuropathic pain: the pharmacological management of neuropathic pain in adults in non-specialist settings www.nice.org.uk\/guidance\/CG96 2010"},{"key":"10.1002\/14651858.CD009183.pub2-BIB0036|cit36","doi-asserted-by":"publisher","first-page":"c3515","DOI":"10.1136\/bmj.c3515","article-title":"Small study effects in meta-analyses of osteoarthritis trials: meta-epidemiological study","volume":"341","author":"N\u00fcesch","year":"2010","journal-title":"BMJ"},{"issue":"4","key":"10.1002\/14651858.CD009183.pub2-BIB0037|cit37","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD005454.pub2","article-title":"Antidepressants for neuropathic pain","author":"Saarto","year":"2007","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"2","key":"10.1002\/14651858.CD009183.pub2-BIB0038|cit38","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1111\/j.1365-2125.2008.03200.x","article-title":"Enriched enrollment: definition and effects of enrichment and dose in trials of pregabalin and gabapentin in neuropathic pain. A systematic review","volume":"66","author":"Straube","year":"2008","journal-title":"British Journal Clinical Pharmacology"},{"key":"10.1002\/14651858.CD009183.pub2-BIB0039|cit39","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/1471-2377-8-29","article-title":"Duloxetine for painful diabetic neuropathy and fibromyalgia pain: systematic review of randomised trials","volume":"8","author":"Sultan","year":"2008","journal-title":"BMC Neurology"},{"issue":"2","key":"10.1002\/14651858.CD009183.pub2-BIB0040|cit40","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.mehy.2004.07.019","article-title":"The epsilon theory: a novel synthesis of the underlying molecular and electrophysiological mechanisms of primary generalized epilepsy and the possible mechanism of action of valproate","volume":"64","author":"Toth","year":"2005","journal-title":"Medical Hypotheses"},{"issue":"3","key":"10.1002\/14651858.CD009183.pub2-BIB0041|cit41","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD001133.pub2","article-title":"Anticonvulsant drugs for acute and chronic pain","author":"Wiffen","year":"2005","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"1","key":"10.1002\/14651858.CD009183.pub2-BIB0042|cit42","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD005451.pub2","article-title":"Carbamazepine for acute and chronic pain in adults","author":"Wiffen","year":"2011","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"2","key":"10.1002\/14651858.CD009183.pub2-BIB0043|cit43","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD006044.pub3","article-title":"Lamotrigine for acute and chronic pain","author":"Wiffen","year":"2011","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD009183.pub2-BIB0044|cit44","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1002\/art.1780330203","article-title":"The American College of Rheumatology 1990 Criteria for the Classification of Fibromyalgia. Report of the Multicenter Criteria Committee","volume":"33","author":"Wolfe","year":"1990","journal-title":"Arthritis and Rheumatism"},{"key":"10.1002\/14651858.CD009183.pub2-BIB0045|cit45","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1002\/acr.20140","article-title":"The American College of Rheumatology preliminary diagnostic criteria for fibromyalgia and measurement of symptom severity","volume":"62","author":"Wolfe","year":"2010","journal-title":"Arthritis Care and Research"},{"issue":"7610","key":"10.1002\/14651858.CD009183.pub2-BIB0046|cit46","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1136\/bmj.39213.565972.AE","article-title":"Effects of treatments for symptoms of painful diabetic neuropathy: systematic review","volume":"335","author":"Wong","year":"2007","journal-title":"BMJ"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1002\/14651858.CD009183.pub2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,9]],"date-time":"2021-08-09T22:28:57Z","timestamp":1628548137000},"score":1,"resource":{"primary":{"URL":"https:\/\/doi.wiley.com\/10.1002\/14651858.CD009183.pub2"}},"subtitle":[],"editor":[{"name":"Cochrane Pain, Palliative and Supportive Care Group","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2011,10,5]]},"references-count":46,"URL":"https:\/\/doi.org\/10.1002\/14651858.cd009183.pub2","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,10,5]]}}}